Heron Therapeutics
HRTX
$2.45
Share price
-3.92%
Change (1 day)
2.51%
Change (1 year)
Categories
Heron Therapeutics (HRTX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.25 B
According to Heron Therapeutics's latest financial reports the company's total liabilities are $0.25 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Heron Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.25 B | 8.05% |
| 2022-12-31 | $0.23 B | 4.05% |
| 2021-12-31 | $0.22 B | 94.88% |
| 2020-12-31 | $0.11 B | 7.45% |
| 2019-12-31 | $0.10 B | 18.4% |
| 2018-12-31 | $92.01 M | -10.81% |
| 2017-12-31 | $0.10 B | 16.27% |
| 2016-12-31 | $88.73 M | 349.62% |
| 2015-12-31 | $19.73 M | 44.9% |
| 2014-12-31 | $13.62 M | 94.79% |
| 2013-12-31 | $6.99 M | 68.32% |
| 2012-12-31 | $4.15 M | 12.48% |
| 2011-12-31 | $3.69 M | 131.54% |
| 2010-12-31 | $1.59 M | -25.99% |
| 2009-12-31 | $2.15 M | -48.71% |
| 2008-12-31 | $4.2 M | -43.79% |
| 2007-12-31 | $7.47 M | 43.99% |
| 2006-12-31 | $5.19 M | 87.71% |
| 2005-12-31 | $2.76 M | -3.29% |
| 2004-12-31 | $2.86 M | 51.16% |
| 2003-12-31 | $1.89 M | -18.52% |
| 2002-12-31 | $2.32 M | -46.44% |
| 2001-12-31 | $4.33 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 SurModics SRDX | $58.09 M | -77.35% | 🇺🇸 USA |
 Pacira Biosciences
PCRX | $0.70 B | 174.59% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $86.3 M | -66.35% | 🇺🇸 USA |
 Alkermes ALKS | $0.93 B | 263.98% | 🇮🇪 Ireland |
 Nektar Therapeutics
NKTR | $0.26 B | 4.12% | 🇺🇸 USA |